Source: BMJ Open. Unidades: FM, FMRP, ICB, FMVZ
Subjects: MICROBIOLOGIA, TUBERCULOSE PULMONAR, GENOMAS, ANTIBIÓTICOS, ENSAIO CLÍNICO, MYCOBACTERIUM TUBERCULOSIS, SEQUENCIAMENTO GENÉTICO, TUBERCULOSE
ABNT
ROSA, Claudio Damião et al. Impact of drug-resistance diagnosis based on whole-genome sequencing on the treatment adequacy of patients with drug-resistant pulmonary tuberculosis in the state of São Paulo, Brazil: a protocol for a non-randomised controlled trial (Gen-TB PróCura). BMJ Open, v. 15, 2025Tradução . . Disponível em: https://doi.org/10.1136/bmjopen-2025-098861. Acesso em: 30 abr. 2026.APA
Rosa, C. D., Ferrazoli, L., Santos, D. P. dos, Pedace, C. S., Camargo, N. C. S., Pereira, T. T. S., et al. (2025). Impact of drug-resistance diagnosis based on whole-genome sequencing on the treatment adequacy of patients with drug-resistant pulmonary tuberculosis in the state of São Paulo, Brazil: a protocol for a non-randomised controlled trial (Gen-TB PróCura). BMJ Open, 15. doi:10.1136/bmjopen-2025-098861NLM
Rosa CD, Ferrazoli L, Santos DP dos, Pedace CS, Camargo NCS, Pereira TTS, Brandão AP, Bollela VR, Cruz ALG, Feliciano CS, Ferreira PRA, Jorge EP, Miranda SS de, Oliveira RS de, Oliveira M de LV, Orlandi GM, Pinhata JMW, Resende MR, Rodrigues C, Sales RKB de, Sakabe S, Chimara E, Guimarães AM de S. Impact of drug-resistance diagnosis based on whole-genome sequencing on the treatment adequacy of patients with drug-resistant pulmonary tuberculosis in the state of São Paulo, Brazil: a protocol for a non-randomised controlled trial (Gen-TB PróCura) [Internet]. BMJ Open. 2025 ; 15[citado 2026 abr. 30 ] Available from: https://doi.org/10.1136/bmjopen-2025-098861Vancouver
Rosa CD, Ferrazoli L, Santos DP dos, Pedace CS, Camargo NCS, Pereira TTS, Brandão AP, Bollela VR, Cruz ALG, Feliciano CS, Ferreira PRA, Jorge EP, Miranda SS de, Oliveira RS de, Oliveira M de LV, Orlandi GM, Pinhata JMW, Resende MR, Rodrigues C, Sales RKB de, Sakabe S, Chimara E, Guimarães AM de S. Impact of drug-resistance diagnosis based on whole-genome sequencing on the treatment adequacy of patients with drug-resistant pulmonary tuberculosis in the state of São Paulo, Brazil: a protocol for a non-randomised controlled trial (Gen-TB PróCura) [Internet]. BMJ Open. 2025 ; 15[citado 2026 abr. 30 ] Available from: https://doi.org/10.1136/bmjopen-2025-098861
